503B CAPA Inspection Response Record

RECORD — IN PREPARATION

Four authorization moments. One inspection-grade record. ~12–18 minutes.

Paste your IRR session ID

DECISION TYPE — LOCKED CAPA Full Authorization Arc · Initiation · Action Plan · Extensions · Effectiveness

Step 1 of 6 · CAPA Identity

Identify the record under inspection.

Basic identifiers an investigator will use to locate this CAPA in your QMS. ~90 seconds.

CAPA ID Originating deviation ID

Facility name FDA FEI number

Decision owner (name) Decision owner title

Step 2 of 6 · Initiation Authorization

Why was the CAPA classified, scoped, and root-caused this way?

The first authorization moment. Investigators challenge severity, root cause acceptance, and scope independently of closure. ~3 minutes.

Severity classification & reasoning Root cause & basis for accepting it Alternative root causes considered & rejected Scope — what is in & what is deliberately out

Step 3 of 6 · Action Plan Authorization

Why this plan, timeline, and owner?

The second authorization moment. The plan an investigator will compare to the alternatives you considered. ~3 minutes.

Corrective & preventive actions Alternatives considered & rejected Timeline reasoning Owner selection reasoning Interim exposure during plan execution

Step 4 of 6 · Extension Authorization

Did the CAPA close on the original target?

Extensions are the highest-exposure authorization moment in the arc. If none were issued, you state that affirmatively below. If any were issued, each is its own authorization record.

No extensions issued. CAPA closed on or before original target close date. One or more extensions were issued. Each must be documented as a standalone authorization.

Step 5 of 6 · Effectiveness Authorization

Why was closure justified at this point?

The reasoning the investigator interrogates hardest. Convergent evidence, explicit exclusions, recurrence hypotheses ruled out, residual exposure. ~5 minutes.

Effectiveness window — start Effectiveness window — end

Window reasoning

Convergent evidence streams (minimum 3 independent streams)

Absence-of-deviations alone is not sufficient. The strength of the authorization is in convergence.

Evidence explicitly not relied upon

Evidence reviewed but consciously rejected. Preserving exclusion logic makes reasoning reconstructable in both directions.

Alternative recurrence hypotheses ruled out

The investigator will reconstruct failure modes. Show you reconstructed them first.

Residual exposure — what remains & why it's acceptable

Step 6 of 6 · Authorization & Delivery

Final authorization chain and regulatory anchors.

The signature trail across all four moments and the regulations your reasoning aligns to. ~2 minutes.

Approval chain (all four moments)

Regulatory anchors (select all that apply)

21 CFR 211.192 Production record review & CAPA effectiveness 21 CFR 211.100 Written procedures; deviations 21 CFR 211.113 Microbiological contamination control USP <797> Sterile compounding USP <1116> Microbiological control of aseptic environments FDA 503B cGMP Outsourcing Facility (2020) ICH Q10 Pharmaceutical Quality System FDA Quality Systems Guidance Closure on demonstrated effectiveness

Delivery email

You'll receive a structured PDF authorization record ready for QMS upload (Veeva, MasterControl, TrackWise, ETQ). Filename: IRR-{CAPA-ID}-{YYYYMMDD}.pdf. CAPA ID, decision owner, and regulatory anchors embedded as PDF metadata.

You'll see a preview of the record and gap analysis across all four authorization moments before payment. Payment unlocks the full record.

The investigator walks the full CAPA arc. This is the record that survives every step.